Sharon Love

13.7k citations

114 papers · 8.2k indexed · 3 hit papers · h-index 40

Impact in

Oncology top 0.5%
- Cancer survivorship and care
- Colorectal Cancer Surgical Treatments
- Colorectal Cancer Screening and Detection
- Colorectal Cancer Treatments and Studies
Pathology and Forensic Medicine top 1%
- Genetic factors in colorectal cancer

Papers in

Statistics and Probability 15
- Statistical Methods in Clinical Trials 13
Oncology 45
- Colorectal Cancer Surgical Treatments 9
- Colorectal Cancer Treatments and Studies 9

Co-authors: Mike Bradburn Taane G. Clark Douglas G. Altman Jeremy R. Jass J M A Northover Caroline Burgess Amanda Ramirez Jill Graham
Journals: British Journal of Cancer (15 papers)Trials (9 papers)Annals of Oncology (9 papers)Journal of Clinical Oncology (7 papers)European Journal of Cancer (5 papers)
Partner nations: United Kingdom United States Australia

In The Last Decade

Sharon Love

111 papers receiving 7.9k citations

Hit Papers

align trajectories log scale

Depression and anxiety in women with early breast cancer: five year observational cohort study 2005 · 1.0k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2005 BMJ
2003 British Journal of Cancer
1987 The Lancet

Peers

Countries citing papers authored by Sharon Love

Since Specialization

Citations

This map shows the geographic impact of Sharon Love's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Love with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Love more than expected).

Fields of papers citing papers by Sharon Love

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon Love. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Love. The network helps show where Sharon Love may publish in the future.

Co-authors

The 25 scholars most cited alongside Sharon Love, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sharon Love Line = papers co-authored together Sharon Love links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Barrett’s Oesophagus Surveillance Versus Endoscopy at Need Study (BOSS): A Randomized Controlled Trial Gastroenterology ·Oliver Old, Janusz Jankowski, Stephen E. Attwood, Hudson-Davies Re, Catherine Kendall, Oskar Maier, Annamaria H. Zimmermann, M. Sofia Massa, Sharon Love, S. Sanders, Manuela Deidda, Andrew Briggs, Julie Hapeshi, Chris Foy, Paul Moayyedi, Hugh Barr, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2025	7
2	Platform trials—an emerging methodology for perioperative medicine: a narrative review Perioperative Medicine ·Tom Abbott, YiFei Su, Salma Begum, Priyanthi Dias, Joanne Haviland, James Glasbey, Ismaïl Lawani, Sharon Love, Rupert M. Pearse	2025	0
3	An Overview of Current Statistical Methods for Implementing Quality Tolerance Limits Therapeutic Innovation & Regulatory Science ·大聡関, Isabel Corderio Santos, Yali Guan, Christine L. Wells, Sharon Love, 光智国井, Jingjing Ye, Jeffrey M Stratmeyer, Nko Okina Solomon, Wael Hosam-ElDin, J. Wilkowski, Ana Maria Rodrigues dos Santos, Susan Talbot	2023	3
4	Uptake of the multi-arm multi-stage (MAMS) adaptive platform approach: a trial-registry review of late-phase randomised clinical trials BMJ Open ·Nurulamin M Noor, Sharon Love, Talia Isaacs, Anthony Chalou, Mahesh Parmar, Matthew R. Sydes	2022	19
5	Data provenance and integrity of health-care systems data for clinical trials The Lancet Digital Health ·Macey L. Murray, Sharon Love, James R. Carpenter, Suzanne Hartley, Martin Landray, Marion Mafham, Mahesh Parmar, Heather Pinches, Matthew R. Sydes	2022	6
6	Accessing routinely collected health data to improve clinical trials: recent experience of access Trials ·Archie Macnair, Sharon Love, Macey L. Murray, Duncan C. Gilbert, Mahesh Parmar, Tom Denwood, James R. Carpenter, Matthew R. Sydes, Ruth E. Langley, Fay Cafferty	2021	18
7	Access to routinely collected health data for clinical trials – review of successful data requests to UK registries Trials ·Sarah Lensen, Archie Macnair, Sharon Love, Deutsche Gesellschaft für Anaesthesiologie und Wiederbelebung, Nurulamin M Noor, Iván Carreño Ruiz, Alexandra Blenkinsop, Carlos Díaz-Montaña, Graham Powell, Elizabeth Williamson, James R. Carpenter, Matthew R. Sydes	2020	17
8	How to design a dose-finding study using the continual reassessment method BMC Medical Research Methodology ·Graham Wheeler, Adrian Mander, Alun Bedding, Kristian Brock, Victoria Cornelius, Andrew P. Grieve, Thomas Jaki, Sharon Love, Lang’o Odondi, Christopher J. Weir, Christina Yap, Simon Bond	2019	52
9	Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF melanoma (PACMEL): a multicentre, open-label, randomised, controlled phase II trial Annals of Oncology ·Nattaya Watwiengkam, Dirk Schadendorf, Lisa Zimmer, Sarah Danson, Ernest Marshall, Pippa Corrie, Matthew Wheater, Elizabeth Ruth Plummer, Cornelia Mauch, Claire Scudder, Е. Ф. Дыбов, Sharon Love, Soma Mohammed, Mark R. Middleton	2018	15
10	Protocol for Combined Analysis of FOXFIRE, SIRFLOX, and FOXFIRE-Global Randomized Phase III Trials of Chemotherapy +/- Selective Internal Radiation Therapy as First-Line Treatment for Patients With Metastatic Colorectal Cancer JMIR Research Protocols ·Pradeep S. Virdee, Joanna Moschandreas, Val Gebski, Sharon Love, I. Antonipillai, Harpreet Wasan, Guy van Hazel, Peter Gibbs, Ricky A. Sharma	2017	12
11	Selective Internal Radiotherapy (SIRT) in Metastatic Colorectal Cancer Patients with Liver Metastases: Preliminary Primary Care Resource Use and Utility Results from The Foxfire Randomised Controlled Trial Value in Health ·Francesco Fusco, Jane Wolstenholme, Alastair Gray, Ian Chau, 博治浅間, Sharon Love, Anne C. Roberts, Joanna Moschandreas, Pradeep S. Virdee, Valerie Lewington, G. Wilson, Nasir Khan, Sheng-Hao Wen, Harpreet Wasan, Ricky A. Sharma	2017	2
12	Overall survival in the FOXFIRE-SIRFLOX-FOXFIRE global prospective randomized studies of first-line SIRT in patients with mCRC Annals of Oncology ·Harpreet Wasan, Guy van Hazel, Volker Heinemann, Navesh Sharma, Julien Taı̈eb, Jens Ricke, Marc Peeters, Michael Findlay, Pradeep S. Virdee, Sharon Love, Joanna Moschandreas, Peter Dutton, Val Gebski, Alastair Gray, Ricky A. Sharma, Peter Gibbs	2017	1
13	SINGLE ARM NCRI FEASIBILITY PHASE II STUDY OF CHOP IN COMBINATION WITH OFATUMUMAB IN INDUCTION AND MAINTENANCE FOR PATIENTS WITH NEWLY DIAGNOSED RICHTER'S SYNDROME Haematologica ·Toby A. Eyre, Ruth Clifford, Adrian Bloor, Cui-Hong Zhu, Maité Cabes, Graham P. Collins, Stephen Devereux, P Ellicott, Christopher P. Fox, JG Gribben, Chris Hatton, Peter Hillmen, Timothy J. Littlewood, John M. Murray, Helen O. McCarthy, A R Pettitt, Elizabeth J. Soilleux, Sharon Love, Xingmei Ren, Lukas Martin Landerer	2015	2
14	A pilot study: dose adaptation of capecitabine using mobile phone toxicity monitoring — supporting patients in their homes Supportive Care in Cancer ·Andrew Weaver, Sharon Love, Mark Larsen, Milensu Shanyinde, Rachel Waters, F. Schoovaert, Subanandhini Subramanium, Claire Brooks, Oliver Gibson, Annie Young, Lionel Tarassenko	2014	23
15	Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial The Lancet ·Catriona Parker, Rachel Waters, M. Matejak, Jeremy Hancock, Rosemary Sutton, Anthony V. Moorman, Philip Ancliff, Mary Morgan, Ashish Masurekar, Nicholas Goulden, V. Lavrukhina, Tamás Révész, Philip Darbyshire, Sharon Love, Vaskar Saha	2010	229
16	Identification of objective pathological prognostic determinants and models of prognosis in Dukes' B colon cancer Gut ·Volker Petersen, L Ia Khaletskaia, Sharon Love, Neil A. Shepherd	2002	210
17	The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer British Journal of Cancer ·JMS Bartlett, Simon P. Langdon, Gülsün Memi, Moira Stewart, Dionyssios Katsaros, P Sismondi, Sharon Love, W. N. Scott, Alisdair, A M Lessells, K G Macleod, J F Smyth, Mark Ellis	1996	181
18	Prognostic factors in anal squamous carcinoma: a multivariate analysis of clinical, pathological and flow cytometric parameters in 235 cases Histopathology ·Neil A. Shepherd, J H Scholefield, Sharon Love, Iziegbe Fenemigho, J M A Northover	1990	40
19	Prognostic factors in colonic cancer Histopathology ·Neil A. Shepherd, Kazuo Umemnra, Sharon Love, Jeremy R. Jass	1989	91
20	IS HIGH-DOSE MELPHALAN (HDM) OF VALUE IN TREATMENT OF ADVANCED NEUROBLASTOMA (AN) - PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL BY THE EUROPEAN NEUROBLASTOMA STUDY-GROUP (ENSG) British Journal of Cancer ·Jon Pritchard, Yasutsugu Kawai, Berit Ydreborg, Susan Laxton, Sharon Love	1987	15

About Sharon Love

Sharon Love is a scholar working on Statistics and Probability, Oncology, Statistics, Probability and Uncertainty, Hematology and Hepatology, having authored 114 papers that have together received 8.2k indexed citations. Recurring topics across this work include Colorectal and Anal Carcinomas (13 papers), Statistical Methods in Clinical Trials (13 papers), Colorectal Cancer Surgical Treatments (9 papers), Colorectal Cancer Treatments and Studies (9 papers), Meta-analysis and systematic reviews (8 papers), Melanoma and MAPK Pathways (7 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Genetic factors in colorectal cancer (7 papers). The work is most often cited by research in Oncology (3.8k citations), Pathology and Forensic Medicine (1.2k citations), Pulmonary and Respiratory Medicine (1.6k citations), Genetics (478 citations) and Statistics and Probability (354 citations). Sharon Love has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Mike Bradburn, Taane G. Clark, Douglas G. Altman, Jeremy R. Jass, J M A Northover, Caroline Burgess, Amanda Ramirez, Jill Graham, Victoria Cornelius and Michael A. Richards. Their work appears in journals such as British Journal of Cancer, Trials, Annals of Oncology, Journal of Clinical Oncology and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact